BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35393018)

  • 21. The Prognostic Potential of Atrial Natriuretic Peptide on the Development of Postoperative Atrial Fibrillation after Cardiac Surgery.
    Hofer F; Hammer A; Steininger M; Kazem N; Koller L; Steinlechner B; Laufer G; Andreas M; Marculescu R; Hengstenberg C; Wojta J; Niessner A; Sulzgruber P
    Thromb Haemost; 2021 Nov; 121(11):1523-1529. PubMed ID: 33634445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
    Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
    Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation.
    Wöhrle J; Karakas M; Trepte U; Seeger J; Gonska B; Koenig W; Rottbauer W
    PLoS One; 2015; 10(9):e0137464. PubMed ID: 26368980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial Assessment of Natriuretic Peptides in Patients Undergoing Interventional Closure of the Left Atrial Appendage.
    Luani B; Rauwolf T; Groscheck T; Tanev I; Herold J; Isermann B; Schmeisser A; Braun-Dullaeus RC
    Heart Lung Circ; 2018 Jul; 27(7):828-834. PubMed ID: 28818408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction.
    Meune C; Twerenbold R; Drexler B; Balmelli C; Wolf C; Haaf P; Reichlin T; Irfan A; Reiter M; Zellweger C; Meissner J; Stelzig C; Freese M; Capodarve I; Mueller C
    Am J Cardiol; 2012 Apr; 109(8):1117-23. PubMed ID: 22257708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
    Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
.
    Maruyama K; Uchiyama S; Shiga T; Iijima M; Ishizuka K; Hoshino T; Kitagawa K
    Cerebrovasc Dis Extra; 2017; 7(1):35-43. PubMed ID: 28253498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR-proANP level predicts new onset atrial fibrillation in patients with acute myocardial infarction.
    Karolina I; Michał K; Marzenna Z
    Biomarkers; 2020 Nov; 25(7):573-577. PubMed ID: 32972251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
    Katan M; Moon Y; von Eckardstein A; Spanaus K; DeRosa J; Gutierrez J; DeCarli C; Wright C; Sacco R; Elkind M
    Stroke; 2017 Mar; 48(3):604-610. PubMed ID: 28123058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MR-proANP measured at admission is associated with incident atrial fibrillation in STEMI patients.
    Wegener A; Modin D; Pedersen S; Lindberg S; Pareek M; Iversen K; Jespersen T; Gislason G; Biering-Sørensen T
    Heart Vessels; 2022 Nov; 37(11):1906-1913. PubMed ID: 35648185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac biomarkers for risk stratification of arrhythmic death in patients with heart failure and reduced ejection fraction.
    Burger AL; Stojkovic S; Diedrich A; Wojta J; Demyanets S; Pezawas T
    Br J Biomed Sci; 2021 Oct; 78(4):195-200. PubMed ID: 33502288
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of a novel score to predict newly diagnosed atrial fibrillation after ischemic stroke: The CHASE-LESS score.
    Hsieh CY; Lee CH; Sung SF
    Atherosclerosis; 2020 Feb; 295():1-7. PubMed ID: 31972497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke.
    Fischer M; Katan M; Morgenthaler NG; Seiler M; Müller B; Lackner P; Errath M; Helbok R; Pfausler B; Beer R; Schmutzhard E; Broessner G
    Cerebrovasc Dis; 2014; 37(2):128-33. PubMed ID: 24481415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea.
    Shah RV; Truong QA; Gaggin HK; Pfannkuche J; Hartmann O; Januzzi JL
    Eur Heart J; 2012 Sep; 33(17):2197-205. PubMed ID: 22645194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
    Berg DD; Ruff CT; Jarolim P; Giugliano RP; Nordio F; Lanz HJ; Mercuri MF; Antman EM; Braunwald E; Morrow DA
    Circulation; 2019 Feb; 139(6):760-771. PubMed ID: 30586727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Simplified Risk Score to Predict In-Hospital Newly-Diagnosed Atrial Fibrillation in Acute Ischemic Stroke Patients.
    Saengmanee T; Thiankhaw K; Tanprawate S; Soontornpun A; Wantaneeyawong C; Teekaput C; Sirimaharaj N; Nudsasarn A
    Int J Gen Med; 2023; 16():1363-1373. PubMed ID: 37096200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
    Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
    Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
    [No Abstract]   [Full Text] [Related]  

  • 40. Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke.
    Buckley BJR; Harrison SL; Hill A; Underhill P; Lane DA; Lip GYH
    Stroke; 2022 May; 53(5):1759-1763. PubMed ID: 35354300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.